Michael Wang

652 total citations
25 papers, 477 citations indexed

About

Michael Wang is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Michael Wang has authored 25 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Michael Wang's work include HIV Research and Treatment (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Michael Wang is often cited by papers focused on HIV Research and Treatment (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Michael Wang collaborates with scholars based in United States, Canada and Greece. Michael Wang's co-authors include Kevin Wang, Bárbara Romero, Yulin Deng, Ivana S. Marková, Geraldine Kenny, Linda Clare, W. Dalton Dietrich, Hui Fan, Helen M. Bramlett and Peter H. Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Michael Wang

20 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wang United States 12 155 152 110 81 72 25 477
Susan Pross United States 19 148 1.0× 53 0.3× 78 0.7× 93 1.1× 50 0.7× 41 921
Kendall A. Marcus United States 11 213 1.4× 157 1.0× 85 0.8× 13 0.2× 109 1.5× 17 585
Ruth Whittington United States 13 122 0.8× 53 0.3× 53 0.5× 18 0.2× 24 0.3× 25 692
Sujata Kelkar United States 6 91 0.6× 53 0.3× 68 0.6× 46 0.6× 16 0.2× 7 610
Jennifer Marquie‐Beck United States 14 50 0.3× 269 1.8× 131 1.2× 28 0.3× 441 6.1× 18 699
Jinxin Lü China 12 223 1.4× 69 0.5× 73 0.7× 10 0.1× 19 0.3× 32 564
Michael Dobbs United States 10 75 0.5× 32 0.2× 95 0.9× 28 0.3× 33 0.5× 33 529
Miloš Marković Serbia 15 88 0.6× 101 0.7× 73 0.7× 102 1.3× 5 0.1× 50 610
Christian Keicher Germany 13 106 0.7× 83 0.5× 144 1.3× 10 0.1× 64 0.9× 21 634
Begoña Cordobilla Spain 13 215 1.4× 49 0.3× 57 0.5× 10 0.1× 26 0.4× 22 566

Countries citing papers authored by Michael Wang

Since Specialization
Citations

This map shows the geographic impact of Michael Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wang more than expected).

Fields of papers citing papers by Michael Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wang. The network helps show where Michael Wang may publish in the future.

Co-authorship network of co-authors of Michael Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wang. A scholar is included among the top collaborators of Michael Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wang. Michael Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Michael, et al.. (2025). Three stages of laboratory stewardship in improving appropriate Clostridioides difficile testing in a community-based setting. Antimicrobial Stewardship & Healthcare Epidemiology. 5(1). e81–e81.
2.
Wang, Michael, et al.. (2024). Streptococcus canis native aortic valve endocarditis linked to cat exposure: A Case Report and Review. Journal of Community Hospital Internal Medicine Perspectives. 14(2). 91–95.
3.
Zhang, Wei, Ke Shi, Qibin Geng, et al.. (2023). Structural evolution of SARS-CoV-2 omicron in human receptor recognition. Journal of Virology. 97(8). e0082223–e0082223. 15 indexed citations
5.
Mehta, Aditya, Richard W. Douce, Michael Wang, et al.. (2023). Clinical Characteristics of the 2019 Eastern Equine Encephalitis Outbreak in Michigan. Open Forum Infectious Diseases. 10(5). ofad206–ofad206. 5 indexed citations
6.
Skinner, Andrew M, et al.. (2021). S183 Infusion of Bezlotoxumab at the End of an Antibiotic Treatment Course for Prevention of Recurrent Clostridioides difficile Infection. The American Journal of Gastroenterology. 116(1). S82–S82.
7.
Wang, Michael, et al.. (2018). How automatic notification of infectious disease specialists impacted the management of Staphylococcus aureus bacteremia in a community hospital setting. Journal of Community Hospital Internal Medicine Perspectives. 8(6). 321–325. 2 indexed citations
8.
Moghieb, Ahmed, Helen M. Bramlett, Zhihui Yang, et al.. (2016). Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury. Molecular & Cellular Proteomics. 15(7). 2379–2395. 34 indexed citations
9.
Wang, Michael, et al.. (2014). “Time Out” For Surgical Safety Checklists?. Neurosurgery. 75(2). N14–N15. 2 indexed citations
10.
Wang, Michael & Stuart Johnson. (2014). Enteric Infections. Cancer treatment and research. 161. 237–251. 7 indexed citations
11.
Yokobori, Shoji, Zuo‐Feng Zhang, Ahmed Moghieb, et al.. (2013). Acute Diagnostic Biomarkers for Spinal Cord Injury: Review of the Literature and Preliminary Research Report. World Neurosurgery. 83(5). 867–878. 84 indexed citations
12.
Parrish, Jay P., L. Tong, Michael Wang, et al.. (2012). Synthesis and biological evaluation of phosphonate analogues of nevirapine. Bioorganic & Medicinal Chemistry Letters. 23(5). 1493–1497. 21 indexed citations
13.
Wang, Michael, Charlesnika T. Evans, Tulio E. Rodriguez, Dale N. Gerding, & Stuart Johnson. (2012). Clostridium difficileInfection and Limitations of Markers for Severity in Patients with Hematologic Malignancy. Infection Control and Hospital Epidemiology. 34(2). 127–132. 33 indexed citations
14.
Mitchell, Michael L., Jong Chan Son, Hongyan Guo, et al.. (2010). N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1589–1592. 12 indexed citations
15.
Mitchell, Michael L., Jong Chan Son, Ill Young Lee, et al.. (2010). N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1585–1588. 19 indexed citations
16.
Marková, Ivana S., Linda Clare, Michael Wang, Bárbara Romero, & Geraldine Kenny. (2005). Awareness in dementia: Conceptual issues. Aging & Mental Health. 9(5). 386–393. 55 indexed citations
17.
Yu, Peter H., et al.. (2004). Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice. American Journal of Physiology-Endocrinology and Metabolism. 286(4). E634–E641. 54 indexed citations
18.
Wang, Michael, et al.. (2003). Manganese superoxide dismutase induction during measles virus infection. Journal of Medical Virology. 70(3). 470–474. 13 indexed citations
19.
Wang, Michael, Albert Schinzel, Dieter Kotzot, et al.. (1999). Molecular and clinical correlation study of Williams-Beuren syndrome: No evidence of molecular factors in the deletion region or imprinting affecting clinical outcome. American Journal of Medical Genetics. 86(1). 34–43. 25 indexed citations
20.
Wang, Michael, Albert Schinzel, Dieter Kotzot, et al.. (1999). Molecular and clinical correlation study of Williams‐Beuren syndrome: No evidence of molecular factors in the deletion region or imprinting affecting clinical outcome. American Journal of Medical Genetics. 86(1). 34–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026